The North America Flow Cytometry Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
The standard setup for an experiment starts with fluorescently tagged cells suspended in a single cell, however, any material containing particles can be used. After being placed over the flow cytometer, the specimen is absorbed into the device, where sheath fluid, a physiological buffer, surrounds the cells. The original sample suspension is organized into a single-file sequence of cells by the fluidics system, which consists of the tubing, pumps, and valves, as they move throughout the flow cytometer for examination.
The interrogation point is the location where laser light interacts with the cells. The phrase laser intercept may also be used to describe it. This is where the event occurs. When a single cell is illuminated by a laser beam, some of the light will hit the internal physical components of the cell and disperse. This light scatter may be quantified and associated with internal cell architecture and relative cell size.
The development of technology and its widespread implementation in a variety of research and diagnostics applications are the main drivers of the North American flow cytometry market. Furthermore, it is anticipated that the use of flow cytometric technologies in diagnostic applications will be stimulated by the rising incidence rates of diseases like cancer and HIV. The market's growth rate is also anticipated to be fueled by the strengthening economies of industrialized nations, like the United States and others.
The US market dominated the North America Flow Cytometry Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,042.3 million by 2028. The Canada market is poised to grow at a CAGR of 10.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 9.3% during (2022 - 2028).
Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Flow Cytometry Market is Estimated to reach $7.7 Billion by 2028, at a CAGR of 8.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.
By Application
By End User
By Technology
By Component
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
